Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 1 2

Status

Unknown 4Completed 2

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 3Breast 1

Conditions

Neoplasms 3Breast Neoplasms 1

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 283Drug Therapy 243apatinib 242Bevacizumab 229camrelizumab 214Etoposide 200Irinotecan 176Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Interventional × indibulin × Clear all
NCT01113970 2013-01-30

Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer

Alaunos Therapeutics

Phase 1/2 Unknown
60 enrolled
Breast

Breast Neoplasms

NCT00591292 2012-07-19

Phase I Study in Advanced Solid Tumors

Alaunos Therapeutics

Phase 1 Unknown
22 enrolled
Tumor-Agnostic

Neoplasms

NCT00591383 2012-07-19

Phase I Study of Indibulin in Combination With Erlotinib in Advanced Solid Tumors

Alaunos Therapeutics

Phase 1 Unknown
10 enrolled
Tumor-Agnostic

Neoplasms

NCT00726687 2012-07-19

Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors

Alaunos Therapeutics

Phase 1/2 Unknown
7 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡